Minerva Stomatol. 2020 May 14. doi: 10.23736/S0026-4970.20.04359-9. [Epub ahead of print]
Abstract
BACKGROUND:
Dental
implants placed in medically compromised patients have predictable
outcomes and a high rate of survival, compared to those placed in
healthy patients. The aims of this study were to observe and compare
implant survival/success rates and soft tissue response to tissue-level
implants placed in healthy and medically compromised patients with a
1-year follow-up.
METHODS:
72 patients, 36 healthy
patients (20 Females and 16 Males) and 36 medically compromised patients
(18 Females and 18 Males) affected by Cardiovascular Diseases
(Arrythmia, Hypertension, Atrial Fibrillation, Bypass and Pacemaker
surgery), Depression, Endocrinous metabolic diseases
(Hypercholesterolemia, Type II Diabetes, Hashimoto's Thyroiditis),
Gastrointestinal diseases (Gastritis, Hiatal Hernia, Gastric Ulcers),
Asthma, Osteoporosis or Glaucoma received one tissue-level implant.
Measurements for primary and secondary outcomes were collected
immediately after implant placement and at 1 year from implant
insertion.
RESULTS:
Three were failed and two were
survived out of a total of 72 implants. Among healthy patients, two
implants failed while one was classified as survived; among Medically
compromised patients one implant failed and another one was classified
as survived. No statistically significant difference was found between
the two groups in terms of success rate or survival rate. No
statistically significant differences between the two groups' marginal
bone level was observed. In healthy patients a mean loss of keratinized
tissue (-0,1±0,6 mm) was reported, while in medically compromised
patients a mean gain was reported (+0,5±0,8 mm).
CONCLUSIONS:
In
terms of Success, Failure and Survival rates, tissue level implants
placed in Healthy and in Medically compromised individuals showed no
short-term (1 year) differences.
Comments